HANAROSTENT® Esophagus

Metal Stent

HANAROSTENT® Esophagus

Olympus offers a lineup of self-expanding metal stents to help achieve luminal patency in a variety of clinical applications. With a unique braiding design, the HANAROSTENT® provides an ideal balance of radial and axial force, allowing for the flexibility to conform to a patient’s anatomy and precisely target their stricture.

HANAROSTENT® Esophagus is a fully covered stent designed to be used for palliative treatment of esophageal stricture and/or trachea-esophageal fistula caused by malignant tumors.

Over-the-wire delivery system is compatible with a 0.035” or 0.038” guidewire.

Indications for Use
The HANAROSTENT® Esophagus (CCC) is indicated for application in palliative treatment of esophageal stricture and/or trachea-esophageal fistula caused by malignant tumors.

Contraindications
This stent is contraindicated for:

  • Strictures that cannot be dilated enough to pass the delivery device.
  • Chronically bleeding tumors, if bleeding is active at the time of placement.
  • Patients for whom the endoscopic treatments are contraindicated.
  • Multiple sites of obstruction
  • Standard endoscopy contraindications
  • Strictures caused by benign tumors
  • Any use other than those mentioned in Indications for Use

Key Benefits

Precise Placement
  • 4 unique gold radiopaque markers at the center of the stent allow for visualization and precise, accurate placement
  • An additional 8 gold radiopaque markers on the proximal and distal ends assist with stent visualizatoin
 
Unique Wire Structure
  • Hook-cross nitnol design provides optimal radial and axial force
 
Anti-Migration
  • Dumbbell heads on both ends for anti-migration
 
Repositioning Function
  • Fully covered body (silicone coating) and lassos on both ends to assist with stent repositioning or removal if necessary
 

Specs